Document is current
Any future updates will be listed below
-
Authors
Teranishi, Kazuki
Wagatsuma, Keisuke
Toda, Keisuke
Nomaru, Hiroko
Yanagihashi, Yuichi
Ochiai, Hiroshi
Akai, Satoru
Mochizuki, Emi
Onda, Yuuki
Nakagawa, Keiji
Sugimoto, Keiki
Takahashi, Shinya
Yamaguchi, Hideto
Ota, Sadao
-
Funding
Funding for this research was provided by:
the New Energy and Industrial Technology Development Organization (20001038-0)
- License Information
-
More Information
Article History
Received: 3 October 2023
Accepted: 3 September 2024
First Online: 19 September 2024
Competing interests
: S.O. is the founder and shareholder of ThinkCyte K.K., a company engaged in the development of an ultrafast machine-vision-based flow cytometers. K.Teranishi, K.Toda, K.W., H.N., Y.Y., S.A., E.M., Y.O. and K.N. have shares of stock options from ThinkCyte K.K., K.Teranishi, K.Toda, K.W., H.N., Y.Y., S.A., E.M., Y.O. and K.N. are employees; H.O. and K.S. are former employees; and S.O. is a board member of ThinkCyte K.K., K.Teranishi, K.Toda, K.N., K.S. and S.O. filed patent applications related to the LF-GC method. S.T. and H.Y. are employees of Astellas Pharma, Inc.
